Aspirin Use Among Adults in the U.S.
- 1 May 2015
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 48 (5) , 501-508
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. populationPharmacoepidemiology and Drug Safety, 2013
- Towards a global brief on aspirinThe Lancet, 2013
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)European Heart Journal, 2012
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trialsThe Lancet Oncology, 2012
- Are we ready to recommend aspirin for cancer prevention?The Lancet, 2012
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2009
- Aspirin Use Among Adults Aged 40 and Older in the United StatesAmerican Journal of Preventive Medicine, 2007